RPL30P14

Across TCGA pan-cancer cohorts, RPL30P14 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL30P14 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPL30P14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL30P14 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LUSC show a favorable association.

UCEC, HNSC, and UVM are the cancer types where RPL30P14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.779	0.887	.002	64	view →
HNSC	DFS	Tertile	All	0.630	0.766	.004	43	view →
UVM	DFS	Median	All	0.558	0.935	<.001	38	view →
KIRC	DFS	Tertile	III,IV	0.568	0.368	.004	34	view →
LUSC	OS	Quartile	All	0.514	0.381	.014	33	view →
LIHC	OS	Quartile	III,IV	0.406	0.724	.001	21	view →
UCS	OS	Quartile	All	0.517	0.889	.005	20	view →
ACC	OS	Tertile	IV	0.245	0.832	.001	20	view →
KIRP	DFS	Median	All	0.873	0.948	.005	18	view →
CESC	DFS	Tertile	All	0.813	0.683	.025	14	view →
CHOL	DFS	Tertile	IV	0.122	0.791	.045	12	view →
OV	OS	Quartile	II,III,IV	0.265	0.370	.030	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL30P14–UCEC (DFS)

Open the UCEC breakdown →